Lack of complete 1p19q deletion in a consecutive series of 12 WHO grade II gliomas involving the insula: A marker of worse prognosis?

Journal of Neuro-Oncology

Volumn 91, Issue 1, 2009, Pages 1-5

  Goze C ^a   Rigau, V ^b   Gibert, L ^a   Maudelonde, T ^a   Duffau, H ^c,d  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b GUI DE CHAULIAC HOSPITAL   (France)

^c Service de Neurochirurgie   (France)

^d CNRS   (France)

Author keywords

1p19q; Insula; WHO grade II glioma

Indexed keywords

ADULT; ARTICLE; ASTROCYTOMA; BRAIN SURGERY; CANCER GRADING; CANCER LOCALIZATION; CHEMOSENSITIVITY; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME DELETION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLIOMA; HETEROZYGOSITY; HUMAN; INSULA; MALE; MOLECULAR GENETICS; OLIGODENDROGLIOMA; PROGNOSIS;

BRAIN MAPPING; BRAIN NEOPLASMS; CEREBRAL CORTEX; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 19; DISEASE PROGRESSION; DNA METHYLATION; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROLOGIC EXAMINATION; RETROSPECTIVE STUDIES; TUMOR SUPPRESSOR PROTEINS; WORLD HEALTH ORGANIZATION;

EID: 57149108259     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-008-9680-8     Document Type: Article

References (34)

1. Pallud J, Mandonnet E, Duffau H, Kujas M, Guillevin R, Galanaud D et al (2006) Prognostic value of initial magnetic resonance imaging growth rates for World Health Organization grade II gliomas. Ann Neurol 60(3):380-383. doi: 10.1002/ana.20946
2. Kujas M, Lejeune J, Benouaich-Amiel A, Criniere E, Laigle-Donadey F, Marie Y et al (2005) Chromosome 1p loss: A favorable prognostic factor in low-grade gliomas. Ann Neurol 58(2):322-326. doi: 10.1002/ana.20543
3. Ricard D, Kaloshi G, Amiel-Benouaich A, Lejeune J, Marie Y, Mandonnet E et al (2007) Dynamic history of low-grade gliomas before and after temozolomide treatment. Ann Neurol 61(5):484-490. doi: 10.1002/ana.21125
4. Laigle-Donadey F, Martin-Duverneuil N, Lejeune J, Criniere E, Capelle L, Duffau H et al (2004) Correlations between molecular profile and radiologic pattern in oligodendroglial tumors. Neurology 63(12):2360-2362
5. Duffau H, Capelle L (2004) Preferential brain locations of low-grade gliomas. Cancer 100(12):2622-2626. doi: 10.1002/cncr.20297
6. Duffau H, Taillandier L, Gatignol P, Capelle L (2006) The insular lobe and brain plasticity: Lessons from tumor surgery. Clin Neurol Neurosurg 108(6):543-548. doi: 10.1016/j.clineuro.2005.09.004
7. Neuloh G, Pechstein U, Schramm J (2007) Motor tract monitoring during insular glioma surgery. J Neurosurg 106(4):582-592. doi: 10.3171/ jns.2007.106.4.582
8. Yasargil M (1996) Microneurosurgery vol IVb. Georg Thieme Verlag, Stuttgart
9. Duffau H, Capelle L, Lopes M, Faillot T, Sichez JP, Fohanno D (2000) The insular lobe: Physiopathological and surgical considerations. Neurosurgery 47(4):801-810. doi: 10.1097/00006123-200010000-00001 discussion 10-1
10. Duffau H, Gatignol P, Mandonnet E, Peruzzi P, Tzourio-Mazoyer N, Capelle L (2005) New insights into the anatomo-functional connectivity of the semantic system: A study using cortico-subcortical electrostimulations. Brain 128(Pt 4):797-810. doi: 10.1093/brain/awh423
11. Duffau H, Lopes M, Arthuis F, Bitar A, Sichez JP, Van Effenterre R et al (2005) Contribution of intraoperative electrical stimulations in surgery of low grade gliomas: A comparative study between two series without (1985-96) and with (1996-2003) functional mapping in the same institution. J Neurol Neurosurg Psychiatry 76(6):845-851. doi: 10.1136/ jnnp.2004.048520
12. Duffau H, Gatignol P, Mandonnet E, Capelle L, Taillandier L Contribution of intraoperative subcortical stimulation mapping of language pathways: a consecutive series of 115 patients operated on for a WHO grade II glioma in the left dominant hemisphere. J Neurosurg (in press)
13. Duffau H, Capelle L, Denvil D, Sichez N, Gatignol P, Taillandier L et al (2003) Usefulness of intraoperative electrical subcortical mapping during surgery for low-grade gliomas located within eloquent brain regions: Functional results in a consecutive series of 103 patients. J Neurosurg 98(4):764-778
14. Berger MS, Deliganis AV, Dobbins J, Keles GE (1994) The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas. Cancer 74(6):1784-1791 10.1002/ 1097-0142(19940915)74:6<1784::AID-CNCR2820740622>3.0.CO;2-D
15. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215. doi: 10.1093/nar/16.3.1215
16. Palmisano WA, Divine KK, Saccomanno G, Gilliland FD, Baylin SB, Herman JG et al (2000) Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 60(21):5954-5958
17. Augustine JR (1996) Circuitry and functional aspects of the insular lobe in primates including humans. Brain Res Brain Res Rev 22(3):229-244. doi: 10.1016/S0165-0173(96)00011-2
18. Yasargil MG, von Ammon K, Cavazos E, Doczi T, Reeves JD, Roth P (1992) Tumours of the limbic and paralimbic systems. Acta Neurochir (Wien) 118(1-2):40-52. doi: 10.1007/BF01400725
19. Vanaclocha V, Saiz N, Panta F (1998) Repair of dural defects in awkward areas-technical note. Acta Neurochir (Wien) 140(6):615-618. doi: 10.1007/ s007010050149
20. Zentner J, Meyer B, Stangl A, Schramm J (1996) Intrinsic tumors of the insula: A prospective surgical study of 30 patients. J Neurosurg 85(2):263-271
21. Duffau H (2006) New concepts in surgery of WHO grade II gliomas: functional brain mapping, connectionism and plasticity - a review. J Neurooncol 79(1):77-115. doi: 10.1007/s11060-005-9109-6
22. Lang FF, Olansen NE, DeMonte F, Gokaslan ZL, Holland EC, Kalhorn C et al (2001) Surgical resection of intrinsic insular tumors: Complication avoidance. J Neurosurg 95(4):638-650
23. Zlatescu MC, Tehrani Yazdi A, Sasaki H, Megyesi JF, Betensky RA, Louis DN et al (2001) Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms. Cancer Res 61(18):6713-6715
24. Mueller W, Hartmann C, Hoffmann A, Lanksch W, Kiwit J, Tonn J et al (2002) Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets. Am J Pathol 161(1):313-319
25. Mariani L, Deiana G, Vassella E, Fathi AR, Murtin C, Arnold M et al (2006) Loss of heterozygosity 1p36 and 19q13 is a prognostic factor for overall survival in patients with diffuse WHO grade 2 gliomas treated without chemotherapy. J Clin Oncol 24(29):4758-4763. doi: 10.1200/ JCO.2006.05.9238
26. Reifenberger J, Reifenberger G, Liu L, James CD, Wechsler W, Collins VP (1994) Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 145(5):1175-1190
27. Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR et al (1998) Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90(19):1473-1479. doi: 10.1093/jnci/90.19.1473
28. Smith JS, Perry A, Borell TJ, Lee HK, O'Fallon J, Hosek SM et al (2000) Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 18(3):636-645
29. Kaloshi G, Benouaich-Amiel A, Diakite F, Taillibert S, Lejeune J, Laigle-Donadey F et al (2007) Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome. Neurology 68(21):1831-1836. doi: 10.1212/01.wnl.0000262034.26310.a2
30. Everhard S, Kaloshi G, Criniere E, Benouaich-Amiel A, Lejeune J, Marie Y et al (2006) MGMT methylation: A marker of response to temozolomide in low-grade gliomas. Ann Neurol 60(6):740-743. doi: 10.1002/ana.21044
31. Alonso ME, Bello MJ, Gonzalez-Gomez P, Arjona D, Lomas J, de Campos JM et al (2003) Aberrant promoter methylation of multiple genes in oligodendrogliomas and ependymomas. Cancer Genet Cytogenet 144(2):134-142. doi: 10.1016/S0165-4608(02)00928-7
32. Mollemann M, Wolter M, Felsberg J, Collins VP, Reifenberger G (2005) Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors. Int J Cancer 113(3):379-385. doi: 10.1002/ ijc.20575
33. Idbaih A, Marie Y, Pierron G, Brennetot C, Hoang-Xuan K, Kujas M et al (2005) Two types of chromosome 1p losses with opposite significance in gliomas. Ann Neurol 58(3):483-487. doi: 10.1002/ana.20607
34. Taillandier L, Duffau H, Perruzi P, Fontaine D, Bauchet L, Baron M et al (2006) Who grade 2 supratentorial gliomas in adults: Analysis of the prognostic factors for the optimization of the therapeutic strategy. Seventh Congress of the European Association for Neurooncology, Vienna, 14-19 September 2006. Neuro-oncology 8(15):046